An economist with the International Center for Law & Economics (ICLE) said that credit card regulations proposed in Congress would reduce competition among credit card issuers.
The managing editor of a financial services website wrote that opponents of credit card regulations proposed in Congress said the regulations could “torpedo” credit card rewards programs.
Federal Trade Commission (FTC) Chair Lina M. Khan said this week that a new report released by her agency shows that three pharmacy benefit managers (PBMs) have “hiked costs” for a range of prescription medications.
The Electronic Payments Coalition (EPC) said this week that it "applauds Congress" for ending the 118th Congress' legislative session without passing the "Credit Card Competition Act of 2023" (CCCA), which is co-sponsored by U.S. Sen. Josh Hawley (R-Mo.)
Richard Hunt, executive chairman of the Electronic Payments Coalition (EPC), said new credit card regulations sponsored by U.S. Sen. Josh Hawley (R-Mo.) are examples of "crony capitalism at its worst."
The Large Urology Group Practice Association (LUGPA) said the federal 340b drug discount program needs more “transparent reporting and oversight.”
A spokesman for the Electronic Payments Coalition (EPC) said the proposed “Credit Card Competition Act” (CCCA), co-sponsored by U.S. Sen. Josh Hawley (R-Mo.), would “force Americans’ credit cards to run on unknown, untested networks.”
Spending on prescription drugs purchased at participating health care providers through the federal 340b drug discount program increased 19% annually between 2010 and 2021.
The executive director of Patients Come First - Missouri (PCF-MO) said there is “growing concern” that the 340b federal drug discount program isn’t passing along drug savings Missouri patients.
Glenn Grossman, the director of research at financial advisory firm Cornerstone Advisors, said the pending federal “Credit Card Competition Act of 2023” (CCCA), co-sponsored by U.S. Sen. Josh Hawley (R-Mo.), could lead to an increase in credit card fraud.
A national monetary and financial markets analyst said that credit card regulations sponsored by U.S. Sen. Josh Hawley (R-Mo) are “bad policy” that will result in higher prices for consumers.
A national healthcare policy analyst said “we don’t actually know” if drug discounts are being passed to patients by Missouri hospitals participating in a federal drug discount program.
Connie Farrow, executive director of Patients Come First-Missouri, said lack of transparency in the federal 340b health care program is a “known concern.”
Connie Farrow, the executive director of newly-formed group, Patients Come First Missouri (PCF-MO), said that the “healthcare system doesn’t work for Missouri patients and families.”
The U.S. House recently passed Missouri U.S. Rep. Jason Smith’s (R-8) bill to ban federal health care programs from “using prices that are based on quality-adjusted life years” (QALYs), but the chair of a national patient care group said that until that bill is signed into law, a state-level bill “is needed to protect people with disabilities.”